Clinical databases in nephrology: Research and clinical practice goals and challenges

Journal of Nephrology

Volumn 19, Issue 5, 2006, Pages 551-555

  Zoccali, Carmine ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

Administrative database; Clinical database; ESRD; Evidence based medicine; Kidney; Observational studies; Uremia

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; RAMIPRIL;

ANTIINFLAMMATORY ACTIVITY; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; COST CONTROL; DRUG EFFICACY; ELECTRONIC MEDICAL RECORD; EVIDENCE BASED MEDICINE; FEEDBACK SYSTEM; HUMAN; INFORMATION RETRIEVAL; KIDNEY; KIDNEY DISEASE; KIDNEY FAILURE; MEDICAL INFORMATION; NEPHROLOGY; NEUROPATHY; OBSERVATIONAL STUDY; QUALITY CONTROL; REVIEW; SODIUM RESTRICTION;

CLINICAL AUDIT; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; KIDNEY DISEASES; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; NEPHROLOGY;

EID: 33947215398     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Cochran WG. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 1968; 24: 295-313.
2. Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis: Part II: multivariate data analysis - an introduction to concepts and methods. BrJ Cancer 2003; 89: 431-6.
3. Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis: Part III: multivariate data analysis - choosing a model and assessing its adequacy and fit. Br J Cancer 2003; 89: 605-11.
4. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, Diaz R, Rashed W, Freeman R, Jiang L, Zhang X, Yusuf S. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006; 368: 647-58.
5. The GISEN Group. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997; 349: 1857-63.
6. Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet 1995; 345: 840-2.
7. Black N. High-quality clinical databases: breaking down barriers. Lancet 1999; 353: 1205-6.
8. Bock PR, Friedel WE, Hanisch J, Karasmann M, Schneider B. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with ωell-established use". Forsch Komplementarmed Klass Naturheilkd 2004; 11 (Suppl 1): 23-9.
9. Grimes DA, Schulz KF. Cohort studies: marching towards outcomes. Lancet 2002; 359: 341-5.
10. Scott JT, Rundall TG, Vogt TM, Hsu J. Kaiser Permanente's experience of implementing an electronic medical record: a qualitative study. BMJ 2005; 331: 1313-6.
11. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-305.
12. Jamtvedt G, Young JM, Kristoffersen DT, Thomson O'Brien MA, Oxman AD. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2003; CD000259.